Owner and operator of a biotechnology research company intended to accelerate drug discovery in areas with high unmet clinical need. The company's research services utilize proprietary quantum bio-chemistry platform to discover compounds that are active against novel, unrelated therapeutic targets associated with various cancers, neurodegeneration conditions and some rare and neglected diseases, enabling doctors to treat liver-stage malaria and African sleeping sickness.